Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.

Consecutive patients receiving New DES without a mixture of other DES

Inclusion Criteria:

• coronary disease amenable to percutaneous coronary intervention (PCI)
• no clinical and lesion limitations

Exclusion Criteria:

• patients with a mixture of several DES
• terminal illness with life expectancy less than 1 year
• patients with cardiogenic shock